High-level accumulation of a recombinant antibody fragment in the periplasm ofEscherichia coli requires a triple-mutant (degP prc spr) host strain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-level accumulation of a recombinant antibody fragment in the periplasm ofEscherichia coli requires a triple-mutant (degP prc spr) host strain

Published:2004 Issue:5 Volume:85 Page:463-474
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnol. Bioeng.

Author:

Chen Christina,Snedecor Brad,Nishihara Julie C.,Joly John C.,McFarland Nancy,Andersen Dana C.,Battersby John E.,Champion Kathleen M.

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference30 articles.

1. Pharmacokinetics of rhuMAb CD18, a Recombinant Humanised Monoclonal Antibody Fragment to CD18, in Normal Healthy Human Volunteers

2. Construction and characterization of Escherichia coli strains deficient in multiple secreted proteases: protease III degrades high-molecular-weight substrates in vivo

3. Degradation of Secreted Proteins in Escherichia coli

4. Affinity–reversed-phase liquid chromatography assay to quantitate recombinant antibodies and antibody fragments in fermentation broth

5. Humanization of an anti-p185HER2 antibody for human cancer therapy.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escherichia coli and Pichia pastoris : microbial cell-factory platform for full-length IgG production;Critical Reviews in Biotechnology;2024-05-26

2. Recombinant laccase production: Escherichia coli, Pichia pastoris, and filamentous fungi as microbial factories;Bacterial Laccases;2024

3. Advances in Escherichia coli-Based Therapeutic Protein Expression: Mammalian Conversion, Continuous Manufacturing, and Cell-Free Production;Biologics;2023-11-29

4. Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System;Current Pharmaceutical Biotechnology;2023-09

5. Expressing antigen binding fragments with high titers in a targeted integration CHO host by optimizing expression vector gene copy numbers and position: A case study;Biotechnology Progress;2022-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3